ADAM12 is expressed in the tumour vasculature and mediates ectodomain shedding of several membrane-anchored endothelial proteins.
about
ADAM12: a genetic modifier of preclinical peripheral arterial disease.Phenotypic diversity of breast cancer-related mutations in metalloproteinase-disintegrin ADAM12ADAM-12 as a diagnostic marker for the proliferation, migration and invasion in patients with small cell lung cancer.Alternative mRNA splicing generates two distinct ADAM12 prodomain variants.ADAM12 and ADAM17 are essential molecules for hypoxia-induced impairment of neural vascular barrier function.Comprehensive Analysis of Genome Rearrangements in Eight Human Malignant Tumor TissuesADAM12-directed ectodomain shedding of E-cadherin potentiates trophoblast fusion.Vascular cell adhesion molecule-1 (VCAM-1)--an increasing insight into its role in tumorigenicity and metastasis.Pivotal role of pervasive neoplastic and stromal cells reprogramming in circulating tumor cells dissemination and metastatic colonization.ADAM12 is a prognostic factor associated with an aggressive molecular subtype of high-grade serous ovarian carcinoma.Erbb2 up-regulation of ADAM12 expression accelerates skin cancer progression.Reverse transendothelial cell migration in inflammation: to help or to hinder?Fine Tuning Cell Migration by a Disintegrin and Metalloproteinases.Tissue inhibitor of metalloproteinases 3-dependent microvascular endothelial cell barrier function is disrupted under septic conditions.ADAM12 and PAPP-A: Candidate regulators of trophoblast invasion and first trimester markers of healthy trophoblasts.ADAM12-L confers acquired 5-fluorouracil resistance in breast cancer cellsADAM12-deficient zebrafish exhibit retardation in body growth at the juvenile stage without developmental defects.ADAM12 Is a Novel Regulator of Tumor Angiogenesis via STAT3 Signaling.Role of genetics in peripheral arterial disease outcomes; significance of limb-salvage quantitative locus-1 genes.Immunotherapeutic Targeting of Tumor-Associated Blood Vessels.
P2860
Q30279037-851F5FB4-6958-48AD-873E-74AF8666ACDCQ30360467-12C8F7BC-5D86-4041-857C-DD9DEA9248B1Q31148772-2D811CF1-1CDC-41E0-A897-6248530A630FQ35014541-5E3DB314-6571-4807-A304-392053105F05Q35917387-D8C82DC8-BC2B-4869-9653-A5584818A617Q36071045-AD46B029-FA2E-4FB4-8DFE-FA2FA05D3D83Q36751530-424B804E-3B65-48CA-8E94-4289FFEE9968Q38207560-92E445F8-5EB5-4163-BE46-CF6A1E33794DQ38293612-9379DDAA-96D5-4329-A3DE-D2BBFD4CA01CQ38880697-15730654-B3A6-41B5-A228-92063715D3B0Q38998305-CE1101F0-ABD3-42B6-847E-91D34EB2E8E6Q39057036-68E89994-58BF-4BDE-AFC9-63CE4B8F2957Q39162354-D262CBC5-77F8-4666-9459-3AF99BB4A1FAQ40749386-01FBA9E1-A0DA-4E56-B733-275C3ED71500Q40874719-98505C30-864C-440A-BE66-DFAB85969D22Q41548025-25CA07C1-2F45-4718-BA30-028914FA885CQ47872366-BB39EBBE-C2ED-499C-A6DE-B6FBE64C4A5DQ48002665-50299413-2974-4AF7-AE01-2E352BE17949Q49332756-8C2E13D7-87CB-4F89-904B-1C519122502FQ49592831-4B0EBB37-A0E0-4528-ADED-6D8205A3D5B3
P2860
ADAM12 is expressed in the tumour vasculature and mediates ectodomain shedding of several membrane-anchored endothelial proteins.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
ADAM12 is expressed in the tum ...... anchored endothelial proteins.
@en
ADAM12 is expressed in the tum ...... anchored endothelial proteins.
@nl
type
label
ADAM12 is expressed in the tum ...... anchored endothelial proteins.
@en
ADAM12 is expressed in the tum ...... anchored endothelial proteins.
@nl
prefLabel
ADAM12 is expressed in the tum ...... anchored endothelial proteins.
@en
ADAM12 is expressed in the tum ...... anchored endothelial proteins.
@nl
P2093
P50
P356
P1433
P1476
ADAM12 is expressed in the tum ...... -anchored endothelial proteins
@en
P2093
Alexander Kotzsch
Camilla Fröhlich
Camilla Nehammer
Carl Blobel
Jens Berthelsen
Julie B Noer
Pauliina Kronqvist
Ulla M Wewer
P304
P356
10.1042/BJ20121558
P407
P577
2013-05-01T00:00:00Z